Back to mobile site

UPDATE: RBC Capital Downgrades Orexigen Therapeutics (OREX) to Sector Perform

February 29, 2016 6:52 AM EST Send to a Friend
(Updated - February 29, 2016 8:24 AM EST)

RBC Capital downgraded Orexigen Therapeutics (NASDAQ: OREX) from Outperform to Sector ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login